Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Multiple Sclerosis

Free Subscription 20.04.2026 2 Arch Phys Med Rehabil 3 BMC Neurol 1 BMJ 1 Int J Neurosci 1 J Neurol 1 J Neurol Neurosurg Psychiatry 1 J Neurosci 2 Mult Scler 2 PLoS One 2 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Phys Med Rehabil

1. NICHOLSON R, Turner AP, Gromisch ES
   Cognitive Strategy Use for Functional Compensation in Multiple Sclerosis: A Systematic Review.
   Arch Phys Med Rehabil. 2026 Apr 15:S0003-9993(26)00651.
   PubMed         Abstract available
   
   
2. JOHNSON KA, DuBose LE, Shah AA, Fling BW, et al
   The Impact of Hormonal Stages of Life in Women with Multiple Sclerosis, A Survey Study: The Menstrual Cycle.
   Arch Phys Med Rehabil. 2026 Apr 13:S0003-9993(26)00644.
   PubMed         Abstract available
   
   

   
   BMC Neurol

3. ERHART DK, Balz LT, Opfer R, Spies L, et al
   Cognition and fatigue in clinically stable multiple sclerosis: EDSS and MRI metrics outperform serum biomarkers.
   BMC Neurol. 2026 Apr 17. doi: 10.1186/s12883-026-04894.
   PubMed        
   
   
4. BISWAS S, Vasireddy S, Srivastava Y, Hamadttu A, et al
   Risk of myocardial infarction in patients with multiple sclerosis: a systematic review and meta-analysis.
   BMC Neurol. 2026 Apr 13. doi: 10.1186/s12883-026-04882.
   PubMed        
   
   
5. KHAND Y, Garg I, Agyei P, Galvez-Jimenez N, et al
   Exploring a possible shared pathophysiology in co-occurrence of multiple sclerosis and Hodgkin lymphoma: a case report and review of literature.
   BMC Neurol. 2026 Apr 13. doi: 10.1186/s12883-026-04889.
   PubMed        
   
   

   
   BMJ

6. DOSHI P
   Multiple sclerosis: Could Roche's bestselling drug Ocrevus be doing more harm than good in women with primary progressive MS?
   BMJ. 2026;393:s666.
   PubMed        
   
   

   
   Int J Neurosci

7. YU Z, Chen H, Zhang Z, Xiong Y, et al
   Bidirectional Mendelian Randomization Study of Causal Associations Between White-Matter Structural Connectivity and Multiple Sclerosis.
   Int J Neurosci. 2026 Apr 13:1-17. doi: 10.1080/00207454.2026.2658643.
   PubMed         Abstract available
   
   

   
   J Neurol

8. SUSINNA C, Restuccia G, Triolo G, Marafioti G, et al
   Iron accumulation in multiple sclerosis and implications for cognitive and clinical progression: a systematic review of advanced neuroimaging studies.
   J Neurol. 2026;273:275.
   PubMed         Abstract available
   
   

   
   J Neurol Neurosurg Psychiatry

9. BUTZKUEVEN H, Kappos L, Wiendl H, Trojano M, et al
   Tysabri Observational Program (TOP): long-term safety and effectiveness of natalizumab treatment in relapsing-remitting multiple sclerosis over 15 years.
   J Neurol Neurosurg Psychiatry. 2026 Apr 16:jnnp-2025-337367.
   PubMed         Abstract available
   
   

   
   J Neurosci

10. FIGLEY TD, Kornelsen J, Uddin MN, Wong K, et al
    White matter damage in multiple sclerosis disproportionately targets default mode, executive control, and salience networks.
    J Neurosci. 2026 Apr 10:e0278252026. doi: 10.1523/JNEUROSCI.0278-25.2026.
    PubMed         Abstract available
    
    

    
    Mult Scler

11. OZEN MS, Aksu Yildirim S
    Effects of motor imagery and action observation combined with standard rehabilitation on walking distance in people with multiple sclerosis: A single-blind exploratory randomized controlled trial.
    Mult Scler. 2026 Apr 16:13524585261435401. doi: 10.1177/13524585261435401.
    PubMed         Abstract available
    
    
12. LEE HL, Lyou HJ, Jeong H, Son JH, et al
    Obstetric and neonatal outcomes in women with multiple sclerosis: A nationwide matched cohort study in Korea.
    Mult Scler. 2026 Apr 14:13524585261434195. doi: 10.1177/13524585261434195.
    PubMed         Abstract available
    
    

    
    PLoS One

13. TAJALI S, Scandiffio J, Ali-Hassan Y, Lim D, et al
    A pilot randomized controlled trial of neuromodulation-augmented balance training in people with multiple sclerosis: STIM-Balance Protocol.
    PLoS One. 2026;21:e0346491.
    PubMed         Abstract available
    
    
14. ZANOTTO T, Tabatabaei A, Lynch SG, He J, et al
    Reducing frailty in frail people with multiple sclerosis: Feasibility of a 6-week multimodal exercise training program.
    PLoS One. 2026;21:e0347063.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

15. MICHEL L
    Cell therapy in multiple sclerosis: An overview.
    Rev Neurol (Paris). 2026 Apr 16:S0035-3787(26)00506.
    PubMed         Abstract available
    
    
16. RIVAL M, Thouvenot E
    Non-infectious environmental risk factors of multiple sclerosis: Mechanisms and intervention windows for prevention.
    Rev Neurol (Paris). 2026 Apr 14:S0035-3787(26)00504.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum